Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

COSTANTINE ALBANY

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1427381607
CMS profile
336710
Location
LAFAYETTE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$4,486.17

95 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,625.00 1
Food and Beverage $1,861.17 94

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 2; records 51–95 of 95 matching records. This page contains 45 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

COSTANTINE ALBANY

NPI 1427381607 · CMS profile ID 336710

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

LAFAYETTE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–95 of 95 matching records. This page contains 45 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427381607?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
COSTANTINE ALBANY, NPI 1427381607, CMS profile ID 336710. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–95 of 95 matching records. This page contains 45 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427381607?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). COSTANTINE ALBANY, NPI 1427381607, CMS profile ID 336710. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–95 of 95 matching records. This page contains 45 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427381607?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
COSTANTINE ALBANY, NPI 1427381607, CMS profile ID 336710, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–95 of 95 matching records. This page contains 45 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1427381607?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

95 matching records · $4,486.17 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 95 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–95 of 95.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $20.8606/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015852655 CMS
Puma Biotechnology, Inc. $15.6406/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059056504 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.1706/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000508073 CMS
AVEO Pharmaceuticals, Inc. $22.5206/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049057543 CMS
E.R. Squibb & Sons, L.L.C. $31.3006/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015852651 CMS
E.R. Squibb & Sons, L.L.C. $19.5106/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015852647 CMS
Merck Sharp & Dohme LLC $18.6005/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048651151 CMS
AstraZeneca Pharmaceuticals LP $20.2905/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011922665 CMS
Genmab U.S., Inc. $19.4005/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343551 CMS
Novartis Pharmaceuticals Corporation $20.6505/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991825547 CMS
Janssen Scientific Affairs, LLC $21.9805/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988522741 CMS
Celgene Corporation $5.8305/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015852615 CMS
Sun Pharmaceutical Industries Inc. $21.9405/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053822463 CMS
AstraZeneca Pharmaceuticals LP $17.9605/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011641799 CMS
Seagen Inc. $19.5205/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995687591 CMS
Amgen Inc. $14.8405/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020557717 CMS
JAZZ PHARMACEUTICALS INC. $20.7604/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058395995 CMS
TerSera Therapeutics LLC $25.0404/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052414919 CMS
Amgen Inc. $13.8704/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019872217 CMS
Genentech USA, Inc. $17.2904/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040333039 CMS
Regeneron Healthcare Solutions, Inc. $18.4604/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999072195 CMS
Incyte Corporation $23.3103/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044593719 CMS
BeiGene USA, Inc. $11.9803/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051186039 CMS
Coherus Biosciences Inc. $20.6903/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060240613 CMS
AstraZeneca Pharmaceuticals LP $19.1903/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015714533 CMS
AstraZeneca Pharmaceuticals LP $24.1203/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012007525 CMS
Gilead Sciences, Inc. $19.5603/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025832037 CMS
AstraZeneca Pharmaceuticals LP $23.1003/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011388685 CMS
Gilead Sciences, Inc. $16.4703/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025947531 CMS
Eisai Inc. $16.2103/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023306045 CMS
Astellas Pharma US Inc $20.5602/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033923555 CMS
Janssen Biotech, Inc. $21.8402/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988235287 CMS
PFIZER INC. $16.7402/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049629005 CMS
PFIZER INC. $13.4402/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049556589 CMS
GENZYME CORPORATION $31.9602/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050162473 CMS
PFIZER INC. $17.7602/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049572689 CMS
Celgene Corporation $19.2701/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015852563 CMS
Sun Pharmaceutical Industries Inc. $23.6801/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053822457 CMS
Coherus Biosciences Inc. $18.7501/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060240585 CMS
Daiichi Sankyo Inc. $20.2701/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006358153 CMS
TerSera Therapeutics LLC $19.8801/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052414915 CMS
CTI BioPharma Corp. $21.0001/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039689243 CMS
AbbVie Inc. $17.3501/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996112541 CMS
GENZYME CORPORATION $19.9401/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050162453 CMS
Merck Sharp & Dohme LLC $24.7101/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048651157 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $57,396.88 62
PY2020 $43,113.67 45
PY2021 $82,654.28 66
PY2022 $22,981.68 46
PY2023 $4,486.17 95
PY2024 $460.82 20
PY2025 $716.07 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $89,550.00 4
PY2023 Principal investigator $309,185.10 12
PY2022 Principal investigator $182,992.50 3
PY2020 Principal investigator $159,845.70 17
PY2019 Principal investigator $135,538.29 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $78,800.00 12/16/2024 Non-covered Recipient Entity
Horizon Oncology & Research Center
An Open-Label Phase 1a,1b Dose-Escalation and Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of AB248 Alone or in Combination with Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1136397171
Principal investigator 1 Veloxis Pharmaceuticals, Inc. $1,250.00 04/26/2024 Non-covered Recipient Entity
HORIZON ONCOLOGY RESEARCH LLC
ASSESS SAFETY AND TOLERABILITY OF ART-123 + FOLFOX + BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS No dispute reported 06/30/2026 1147094710
Principal investigator 1 Veloxis Pharmaceuticals, Inc. $5,750.00 04/08/2024 Non-covered Recipient Entity
HORIZON ONCOLOGY RESEARCH LLC
ASSESS SAFETY AND TOLERABILITY OF ART-123 + FOLFOX + BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS No dispute reported 06/30/2026 1147094702
Principal investigator 1 Veloxis Pharmaceuticals, Inc. $3,750.00 03/20/2024 Non-covered Recipient Entity
HORIZON ONCOLOGY RESEARCH LLC
ASSESS SAFETY AND TOLERABILITY OF ART-123 + FOLFOX + BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS No dispute reported 06/30/2026 1147094700